Germline Whole‐Exome Sequencing in Non‐Smoker Lung Cancer Patients Reveals Pathogenic Variants in Lung Cancer Driver Genes
Genes, Chromosomes and Cancer · 2025
DOI: 10.1002/gcc.70040 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes, Chromosomes and Cancer, 2025. Verfasst von Giovanni Carapezza und 10 weiteren Autor:innen. Beteiligte Einrichtung: Cogentech S.R.L.Benefit C. With Only Stakeholder Fondazione IFOM ETS, Milano, Italy. Hauptthemen laut MEDLINE: Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, Non-Smokers. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ministry of Health "Ricerca Corrente", Associazione Italiana Ricerca sul Cancro.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Approximately 10%–15% of all lung cancers arise in non‐smokers. Although there are no established aetiological factors, non‐smokers with a family history of cancer have an increased risk of lung cancer, implying host genetic factors in lung cancer susceptibility. We sought to identify, in a cohort of 75 patients recruited before lung lobectomy, germline alterations with a strong association with lung cancer. Whole‐exome sequencing was performed on genomic DNA from peripheral blood. Six resources were used to select pathogenic germline variants with strong clinical significance. In total, 33 pathogenic or likely pathogenic variants in 31 genes were identified. Of these, 13 were located in cancer‐predisposing genes (nine were lung cancer drivers), most of which were involved in DNA repair mechanisms and diseases of metabolism. Among DNA repair‐related genes, BRCA1 and BRCA2 , and ATM have also been identified in other studies on non‐smokers. Our results strongly support the hypothesis that a number of non‐smoker lung cancer patients carry germline variants in cancer‐predisposing genes, suggesting that lung cancer patients, particularly non‐smokers, should be considered for germline molecular testing.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cogentech S.R.L.Benefit C. With Only Stakeholder Fondazione IFOM ETS, Milano, Italy.
- Fondazione IRCCS Istituto Nazionale Dei Tumori, Milano, Italy.
- Ospedale San Giuseppe, IRCCS Multimedica, Milano, Italy.
- Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy.
- National Research Council, Institute for Biomedical Technologies, Segrate, Italy.
ORCID-Profile: Simone Paolo Minardi, Manuela Gariboldi
Förderung
- Ministry of Health "Ricerca Corrente"
- Associazione Italiana Ricerca sul Cancro
Zitieren
APA
Carapezza, G., Minardi, S. P., Noci, S., Pintarelli, G., Zanutto, S., Incarbone, M., Tosi, D., Dragani, T. A., Colombo, F., Pierotti, M. A., & Gariboldi, M. (2025). Germline Whole‐Exome Sequencing in Non‐Smoker Lung Cancer Patients Reveals Pathogenic Variants in Lung Cancer Driver Genes. Genes, Chromosomes and Cancer. https://doi.org/10.1002/gcc.70040
Vancouver
Carapezza G, Minardi SP, Noci S, Pintarelli G, Zanutto S, Incarbone M, et al. Germline Whole‐Exome Sequencing in Non‐Smoker Lung Cancer Patients Reveals Pathogenic Variants in Lung Cancer Driver Genes. Genes, Chromosomes and Cancer. 2025. doi:10.1002/gcc.70040
BibTeX
@article{Carapezza2025,
author = {Carapezza, Giovanni and Minardi, Simone Paolo and Noci, Sara and Pintarelli, Giulia and Zanutto, Susanna and Incarbone, Matteo and Tosi, Davide and Dragani, Tommaso Antonio and Colombo, Francesca and Pierotti, Marco Alessandro and Gariboldi, Manuela},
title = {Germline Whole‐Exome Sequencing in Non‐Smoker Lung Cancer Patients Reveals Pathogenic Variants in Lung Cancer Driver Genes},
journal = {Genes, Chromosomes and Cancer},
year = {2025},
doi = {10.1002/gcc.70040}
}
EUVIMED